These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3099641)

  • 1. Penetration of aztreonam into cerebrospinal fluid and brain of noninfected rabbits and rabbits with experimental meningitis caused by Pseudomonas aeruginosa.
    Strausbaugh LJ; Bodem CR; Laun PR
    Antimicrob Agents Chemother; 1986 Nov; 30(5):701-4. PubMed ID: 3099641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin in experimental Pseudomonas aeruginosa meningitis in rabbits.
    Hackbarth CJ; Chambers HF; Stella F; Shibl AM; Sande MA
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():65-9. PubMed ID: 3100492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of aztreonam in therapy for experimental bacterial meningitis and cerebritis.
    Scheld WM; Brodeur JP; Foresman PA; Gratz JC; Rodeheaver GT
    Rev Infect Dis; 1985; 7 Suppl 4():S635-47. PubMed ID: 3909319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of aztreonam into cerebrospinal fluid of patients with bacterial meningitis.
    Modai J; Vittecoq D; Decazes JM; Wolff M; Meulemans A
    Antimicrob Agents Chemother; 1986 Feb; 29(2):281-3. PubMed ID: 3717933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and plasma bactericidal activity of aztreonam in low-birth-weight infants.
    Likitnukul S; McCracken GH; Threlkeld N; Darabi A; Olsen K
    Antimicrob Agents Chemother; 1987 Jan; 31(1):81-3. PubMed ID: 3105443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Penetration of aztreonam and ampicillin to cerebrospinal fluid in the concomitant administration to rabbits with Staphylococcus aureus meningitis].
    Okura K; Haruta T; Yamamoto H; Kuroki S; Kobayashi Y
    Jpn J Antibiot; 1985 Nov; 38(11):3378-86. PubMed ID: 4094069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bacteriological, pharmacokinetic and clinical studies on aztreonam in the pediatric field. Pediatric Study Group of Aztreonam].
    Fuyii R; Meguro H; Arimasu O; Sunakawa K; Ishizuka Y; Nakazawa S; Sato H; Narita A; Matsumoto K; Suzuki H
    Jpn J Antibiot; 1985 Nov; 38(11):3195-216. PubMed ID: 3912524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration of aztreonam into human cerebrospinal fluid in the presence of meningeal inflammation.
    Greenman RL; Arcey SM; Dickinson GM; Mokhbat JE; Sabath LD; Platt TB; Friedhoff LT
    J Antimicrob Chemother; 1985 May; 15(5):637-40. PubMed ID: 4040132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential distributions in tissues and efficacies of aztreonam and ceftazidime and in vivo bacterial morphological changes following treatment.
    Turcotte A; Simard M; Morin NJ; Beauchamp D; Bergeron MG
    Antimicrob Agents Chemother; 1997 Feb; 41(2):401-9. PubMed ID: 9021198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo Pharmacodynamics of Colistin and Aztreonam Alone and in Combination against Multidrug-Resistant Pseudomonas aeruginosa.
    Yamagishi Y; Hagihara M; Kato H; Hirai J; Nishiyama N; Koizumi Y; Sakanashi D; Suematsu H; Nakai H; Mikamo H
    Chemotherapy; 2017; 62(2):105-110. PubMed ID: 27788502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of aztreonam in experimental bacterial meningitis and cerebritis.
    Scheld WM; Brodeur JP; Gratz JC; Foresman P; Rodeheaver G
    Antimicrob Agents Chemother; 1983 Nov; 24(5):682-8. PubMed ID: 6362552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aztreonam therapy in experimental meningitis due to Haemophilus influenzae type b and Escherichia coli K1.
    McCracken GH; Sakata Y; Olsen KD
    Antimicrob Agents Chemother; 1985 Apr; 27(4):655-6. PubMed ID: 3890733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic activity of amikacin with aztreonam against Pseudomonas aeruginosa and other gram-negative organisms.
    Greenberg RN; Bollinger M; Compton J
    Clin Ther; 1986; 8(3):354-8. PubMed ID: 3087621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and bacteriological effect of ceftazidime in experimental Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli meningitis.
    Sakata Y; Boccazzi A; McCracken GH
    Antimicrob Agents Chemother; 1983 Feb; 23(2):213-7. PubMed ID: 6340600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration of cefotaxime and moxalactam into cerebrospinal fluid of rabbits with experimentally induced Escherichia coli meningitis.
    Nolan CM; Ulmer C
    Rev Infect Dis; 1982; 4 Suppl():S396-400. PubMed ID: 6294789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bacterial meningitis and Pseudomonas aeruginosa: apropos of a case].
    Batlle Almodóvar Mdel C; Dickinson F; Pérez Monrás M; Tamargo Martínez I; Similis A
    Rev Cubana Med Trop; 2005; 57(3):230-2. PubMed ID: 17969281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of ceftazidime and aztreonam alone or in combination with amikacin in experimental left-sided Pseudomonas aeruginosa endocarditis.
    Pefanis A; Giamarellou H; Karayiannakos P; Donta I
    Antimicrob Agents Chemother; 1993 Feb; 37(2):308-13. PubMed ID: 8452362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoring the activity of the antibiotic aztreonam using the polyphenol epigallocatechin gallate (EGCG) against multidrug-resistant clinical isolates of
    Betts JW; Hornsey M; Higgins PG; Lucassen K; Wille J; Salguero FJ; Seifert H; La Ragione RM
    J Med Microbiol; 2019 Oct; 68(10):1552-1559. PubMed ID: 31419210
    [No Abstract]   [Full Text] [Related]  

  • 19. Aztreonam in the treatment of bacterial meningitis.
    Ayroza-Galvão PA; Milstein-Kuschnaroff TM; Mimica IM; Maassen S; Barbosa Júnior SP; Cavalcante NJ; Lorenco R; Mimica LM; Martino MD
    Chemotherapy; 1989; 35 Suppl 1():39-44. PubMed ID: 2731449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of leukocyte entry into the brain by the selectin blocker fucoidin decreases interleukin-1 (IL-1) levels but increases IL-8 levels in cerebrospinal fluid during experimental pneumococcal meningitis in rabbits.
    Ostergaard C; Yieng-Kow RV; Benfield T; Frimodt-Møller N; Espersen F; Lundgren JD
    Infect Immun; 2000 Jun; 68(6):3153-7. PubMed ID: 10816457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.